YU49422B - Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću - Google Patents
Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošćuInfo
- Publication number
- YU49422B YU49422B YU35398A YU35398A YU49422B YU 49422 B YU49422 B YU 49422B YU 35398 A YU35398 A YU 35398A YU 35398 A YU35398 A YU 35398A YU 49422 B YU49422 B YU 49422B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- medicament
- manufacture
- carbonic anhydrase
- age related
- anhydrase inhibitors
- Prior art date
Links
- 208000001344 Macular Edema Diseases 0.000 title abstract 2
- 206010025415 Macular oedema Diseases 0.000 title abstract 2
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 208000002780 macular degeneration Diseases 0.000 title abstract 2
- 201000010230 macular retinal edema Diseases 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 206010064930 age-related macular degeneration Diseases 0.000 title 1
- 229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 title 1
- 229940122072 Carbonic anhydrase inhibitor Drugs 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Eye Examination Apparatus (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Upotreba oftalmičnih preparata koji sadrži efektivne količine površinskog inhibitora ugljenične anhidraze za proizvodnju medikamenta za površinsku primenu za tretiranje makularnog edema ili makularne degeneracije izazvane starošću. Prijava sadrži još 5 zavisnih patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1225096P | 1996-02-26 | 1996-02-26 | |
GBGB9605642.9A GB9605642D0 (en) | 1996-03-18 | 1996-03-18 | Treatment of macular edema |
Publications (2)
Publication Number | Publication Date |
---|---|
YU35398A YU35398A (sh) | 2001-12-26 |
YU49422B true YU49422B (sh) | 2006-01-16 |
Family
ID=26308946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU35398A YU49422B (sh) | 1996-02-26 | 1997-02-25 | Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0954305B9 (sh) |
JP (1) | JP4392481B2 (sh) |
KR (1) | KR100471586B1 (sh) |
CN (1) | CN1225582A (sh) |
AT (1) | ATE239468T1 (sh) |
AU (1) | AU727565B2 (sh) |
BG (1) | BG64525B1 (sh) |
BR (1) | BR9707674A (sh) |
CA (1) | CA2247063C (sh) |
CZ (1) | CZ299509B6 (sh) |
DE (1) | DE69721824T2 (sh) |
DK (1) | DK0954305T3 (sh) |
EA (1) | EA001681B1 (sh) |
EE (1) | EE03804B1 (sh) |
ES (1) | ES2199348T4 (sh) |
HU (1) | HU227161B1 (sh) |
IL (1) | IL125912A0 (sh) |
IS (1) | IS2053B (sh) |
MX (1) | MXPA98006961A (sh) |
NO (1) | NO320043B1 (sh) |
NZ (1) | NZ331843A (sh) |
PT (1) | PT954305E (sh) |
SK (1) | SK284371B6 (sh) |
TR (1) | TR199801665T2 (sh) |
WO (1) | WO1997030704A2 (sh) |
YU (1) | YU49422B (sh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9716657D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
GB9803226D0 (en) | 1998-02-17 | 1998-04-08 | Zeneca Ltd | Chemical compounds |
WO1999044603A1 (en) * | 1998-03-06 | 1999-09-10 | Sponsel William E | Composition and method for treating macular disorders |
US5948801A (en) * | 1998-03-09 | 1999-09-07 | Alcon Laboratories, Inc. | Treatment of retinal edema with brinzolamide |
CA2336703A1 (en) * | 1998-07-10 | 2000-01-20 | The University Of Sydney | Prophylactic treatments of neovascularisation in macular degeneration |
GB9902459D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
GB9902461D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
GB9902452D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
GB9902453D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
GB9902455D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
GB0000625D0 (en) | 2000-01-13 | 2000-03-01 | Zeneca Ltd | Chemical compounds |
US20030100594A1 (en) * | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
JP2010513262A (ja) | 2006-12-15 | 2010-04-30 | ニコックス エス エイ | カルボニックアンヒドラーゼ阻害剤誘導体 |
AR084194A1 (es) * | 2010-12-09 | 2013-04-24 | Fovea Pharmaceuticals | Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos |
US10040804B2 (en) | 2016-12-21 | 2018-08-07 | Biotheryx, Inc. | Compounds targeting proteins, compositions, methods, and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4797413A (en) * | 1986-05-14 | 1989-01-10 | Merck & Co., Inc. | Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use |
GB2223166B (en) * | 1988-09-29 | 1992-03-18 | American Cyanamid Co | Stable ophthalmic preparations containing methazolamide |
US5153192A (en) * | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
-
1997
- 1997-02-25 EP EP97907822A patent/EP0954305B9/en not_active Expired - Lifetime
- 1997-02-25 AU AU19721/97A patent/AU727565B2/en not_active Ceased
- 1997-02-25 YU YU35398A patent/YU49422B/sh unknown
- 1997-02-25 EE EE9800263A patent/EE03804B1/xx not_active IP Right Cessation
- 1997-02-25 WO PCT/US1997/002874 patent/WO1997030704A2/en active IP Right Grant
- 1997-02-25 DK DK97907822T patent/DK0954305T3/da active
- 1997-02-25 HU HU9902054A patent/HU227161B1/hu not_active IP Right Cessation
- 1997-02-25 CA CA002247063A patent/CA2247063C/en not_active Expired - Fee Related
- 1997-02-25 MX MXPA98006961A patent/MXPA98006961A/es active IP Right Grant
- 1997-02-25 IL IL12591297A patent/IL125912A0/xx not_active IP Right Cessation
- 1997-02-25 AT AT97907822T patent/ATE239468T1/de not_active IP Right Cessation
- 1997-02-25 CN CN97192579A patent/CN1225582A/zh active Pending
- 1997-02-25 ES ES97907822T patent/ES2199348T4/es not_active Expired - Lifetime
- 1997-02-25 CZ CZ0269998A patent/CZ299509B6/cs not_active IP Right Cessation
- 1997-02-25 BR BR9707674-0A patent/BR9707674A/pt not_active Application Discontinuation
- 1997-02-25 NZ NZ331843A patent/NZ331843A/xx not_active IP Right Cessation
- 1997-02-25 KR KR10-1998-0706643A patent/KR100471586B1/ko not_active IP Right Cessation
- 1997-02-25 DE DE69721824T patent/DE69721824T2/de not_active Expired - Lifetime
- 1997-02-25 EA EA199800764A patent/EA001681B1/ru not_active IP Right Cessation
- 1997-02-25 SK SK1151-98A patent/SK284371B6/sk not_active IP Right Cessation
- 1997-02-25 JP JP53037997A patent/JP4392481B2/ja not_active Expired - Fee Related
- 1997-02-25 TR TR1998/01665T patent/TR199801665T2/xx unknown
- 1997-02-25 PT PT97907822T patent/PT954305E/pt unknown
-
1998
- 1998-08-20 IS IS4829A patent/IS2053B/is unknown
- 1998-08-25 NO NO19983906A patent/NO320043B1/no not_active IP Right Cessation
- 1998-09-25 BG BG102797A patent/BG64525B1/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU49422B (sh) | Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću | |
DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
DE69435086D1 (de) | Phenylacetate und Derivate, allein oder in Kombination mit anderen Verbindungen, zur Behandlung von neoplastischen und anderen Erkrankungen | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
DE69326776D1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
SE9803710L (sv) | Användning av vissa substanser för behandling av nervrotsskador | |
TR199801151T2 (xx) | Trombin inhibit�r� �n ila�lar. | |
DK0719154T3 (da) | Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel | |
DE68919358D1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
DE69805973D1 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase | |
DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
HUP9802971A1 (hu) | Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére | |
ATE338575T1 (de) | Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
YU42298A (sh) | Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola | |
RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
ITRM910730A1 (it) | Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali. | |
UA66757C2 (en) | Ophthalmologic composition of carbonic anhydrase inhibitors, method for treating or preventing macular edema or age-related macular degeneration | |
ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
AU8900498A (en) | Compounds and pharmaceutical compositions thereof for eliciting analgesic effects | |
DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine |